Inheritance of Susceptibility to Malignant Blood
Disorders

Viggo Jonsson; Haneef Awan; Neil D Jones4; Luis Rodriguez Redondo; Tom B Johannesen; Bjarni a Steig; Luis Rodriguez Redondo; Geir E Tjonnfjord

Opinion

Inheritance of Susceptibility to Malignant Blood Disorders

Viggo Jonsson*^1,2, Haneef Awan^2,3, Neil D Jones⁴, Tom B Johannesen⁵, Bjarni a Steig^6,7, Gudrid Andosdottir⁷ and Geir E Tjonnfjord ^1,2

¹Department of Hematology, Oslo, Norway

²Institute of Clinical Medicine, Oslo, Norway

³Department of Research Computing, Oslo, Norway

⁴Department of Computer Science, Copenhagen, Denmark

⁵Norwegian Cancer Registry, Oslo, Norway

⁶Department of Medicine, Torshavn, the Faroe Islands

⁷Genetic Biobank, Torshavn, the Faroe Islands

Corresponding Author

Received Date: March 18, 2019; Published Date: March 27, 2019

Abstract

This is a study of familial malignant blood disease (MBD), both lymphoproliferative (LPD) and myeloproliferative (MPD). One group is from Norway and Denmark: 112 families with unrelated parents, in all 301 cases of MBD. This group is compared with 315 patients with MBD from the Faroe Islands. The Faroese population is in effect one large inbred family with related parents. LPD includes the lymphoid leukemias (chronic and acute), the malignant lymphomas (morbus Hodgkin and non-Hodgkin’s lymphomas), multiple myeloma and a few other diagnoses. MPD includes the myeloid leukemias (chronic and acute), myelodysplasia, myelofibrosis, polycythemia vera and essential thrombocytosis.

Article Details

Citation

Viggo Jonsson, Haneef Awan, Neil D Jones, Tom B Johannesen, Bjarni A Steig, et al. Inheritance of Susceptibility to Malignant Blood Disorders. Anaest & Sur On J. 1(1): 2019. ASOAJ.MS.ID.000502.